Page 4 - Pfizer

Tornado damage to Pfizer plant unlikely to cause supply shortages: US FDA

Most of the destruction from a tornado that tore through eastern North Carolina on Wednesday and struck a large Pfizer pharmaceutical plant affected its storage facility, rather than its medicine production areas, the company said on Friday. The drugmaker's ability to salvage production equipment and other essential materials could mitigate what experts feared would be a major blow to an already strained system as the United States grapples with existing drug shortages. We do not expect there to be any immediate significant impacts on supply given the products are currently at hospitals and in the distribution system, US Food and Drug Administration Commissioner Robert Califf said on Friday. An EF3 tornado touched down on Wednesday near Rocky Mount, ripping the roof off a Pfizer factory responsible for producing nearly 25 per cent of the American pharmaceutical giant's sterile injectable medicines used in US hospitals, according to the drugmaker. Pfizer said on Friday that a wareho

Pfizer's proposed $43 bn takeover of Seagen faces EU investigation

If the takeover goes through, Seagen's portfolio would double Pfizer's pipeline of early-stage experimental cancer therapies, Pfizer has said

US: 2 Indian-origin men charged with insider trading with Pfizer Covid meds

Two Indian-origin people, including a former Pfizer employee, have been charged with insider trading by federal authorities for their scheme to reap illicit profits by trading on information about the results of a COVID-19 medicine's clinical trials by the pharmaceutical giant. Amit Dagar, a former Pfizer employee, and his close friend and business partner Atul Bhiwapurkar were charged on Thursday by the US Securities and Exchange Commission (SEC) for their scheme to reap illicit profits through insider trading. In a parallel action, the US Attorney's Office for the Southern District of New York also announced criminal charges against the duo. Dagar, 44, of Hillsborough, New Jersey, was arrested on Thursday and was charged with four counts of securities fraud, each of which carries a maximum sentence of 20 years in prison, and one count of conspiracy to commit securities fraud, carrying a maximum sentence of five years in prison. Bhiwapurkar, 45, of Milpitas, California, was also .

Eli Lilly's 'triple G' anti-obesity drug leads to 24% weight loss in trial

The pharma company published the results of phase two of the clinical trial of Retatrutide, showing impressive weight loss and regulation of blood sugar levels in undertrials

Pfizer to discontinue development of obesity drug due to side effects

Pfizer has been developing treatments to target weight loss in diabetes and obesity patients, as it races to target a market estimated to reach $100 billion by the end the of decade

'Govt kept same rules for Indian, foreign cos while getting Covid vaccines'

Foreign-made vaccines were not procured during the Covid pandemic as the firms were demanding indemnity, which was not made available to Indian vaccine manufacturers, Union Health Minister Mansukh Mandaviya has said, asserting that the "same rule applies for all". He also said that it was wrong to suggest that India stopped foreign made vaccines like that made by Moderna and Pfizer from coming to India. "We may have certain requirements and strengths and other countries may have some other strengths and needs. It is wrong to say that India stopped any country from coming to India.When they applied with required data, we gave them emergency use approvals just like we gave to Indian companies," Mandaviya said in an exclusive interview to PTI recently. However, their demands for indemnification and sovereign immunity waivers were a major impediment and eventually the government did not go ahead with it, the minister stated. "At that time, Sputnik vaccine was also there and so were Ind

Pfizer and GSK to battle for share of new RSV vaccine market: Report

US drugmaker Pfizers and British pharma major GSK are likely to face significant competition in the respiratory syncytial virus (RSV) vaccine market, according to a report on Tuesday

BioNTech faces several lawsuits in Germany over Covid vaccine side effects

German drug company BioNTech is facing hundreds of lawsuits, worth one million euros, in country for alleged health damage due to its Covid-19 vaccine, co-developed with American pharma giant Pfizer

Stocks to Watch today, May 19: ITC, Thomas Cook, Zomato, Nexus REIT, IndiGo

Stocks to Watch on Friday: ITC Limited reported a 21.4 per cent YoY growth in standalone net profit at Rs 5,086.9 crore for the March quarter

Pfizer suspends sale of three antibiotics in India over technical issues

Investigating matter with contract manufacturer Astral Steritech, says pharma firm

Pfizer suspends sale, use of some products in India over quality concerns

Stockists have been asked not to sell, distribute, or use the products until further notice from Pfizer

Pfizer consolidated net profit rises 3% to Rs 130 crore in March quarter

The company said its board recommended a final dividend of Rs 35 per share of Rs 10 each

Pfizer pouring windfall profits from Covid-19 vaccine into cancer battle

The U.S. government will end the COVID Public Health Emergency on Thursday that allowed millions of Americans to receive vaccines, tests and treatments at no cost

Pfizer beats profit estimates as new drugs offset Covid products slump

Pfizer expects 2023 to be a "transition year" for its Covid products, before potential returning to growth in 2024

Pfizer's new bivalent mRNA Covid booster vax highly effective: Lancet

The team found that those who received the bivalent booster dose had a 72% lower risk of Covid related hospitalisation and a 68% lower risk of Covid related death

Seagen acquisition: Pfizer can now bet on future of cancer drugs

Given the muted response to the deal on Monday, analysts seem skeptical that this will be as easy as Pfizer makes it sound

Pfizer to acquire Seagen for $43 bn to deepen reach into treating cancer

Pfizer will spend USD 43 billion to buy Seagen and deepen its reach into treating cancer. The pharmaceutical giant said Monday that it will pay USD 229 per Seagen share. Together, Pfizer and Seagen seek to accelerate the next generation of cancer breakthroughs and bring new solutions to patients by combining the power of Seagen's antibody-drug conjugate (ADC) technology with the scale and strength of Pfizer's capabilities and expertise," Pfizer Chairman and CEO Dr. Albert Bourla said in a statement. Bothell, Washington-based Seagen Inc. is a biotech drug developer. Its key products use monoclonal antibodies that bind to the surface of a tumour cell to deliver a cancer-killing agent while sparing surrounding healthy tissue. Monoclonal antibodies are lab-made proteins delivered mostly by IV at an infusion center, according to the Cleveland Clinic. Seagen's top seller, Adcetris, treats lymph system cancers. It brought in USD 839 million in sales last year, a 19 per cent increase over

Pfizer enters talks to buy Seagen for over $30 billion, says report

Deal will help the firm add to its line-up of cancer treatments

HC directs firm to pay Rs 2 crore damages to Pfizer for contempt of court

The Delhi High Court has directed a firm to pay Rs 2 crore as damages to pharma giant Pfizer Inc for committing wilful" and "contumacious contempt of court by disobeying its order. The court said if the director of the firm, Triveni Interchem Pvt Ltd, fails to pay the amount in two weeks, he shall be taken into custody and detained in a civil prison for two weeks at Tihar jail here. The court, in an interim order, had restrained the firm from making, selling, distributing, advertising, exporting or importing or dealing with any product having compound Palbociclib' or any pharmaceutically acceptable salt as it would infringe the patent of plaintiff Pfizer. As the firm was found continuing to sell Palbociclib, the court held the defendants guilty of wilful disobedience of its order and committing contempt of court. In these circumstances, as the defendants were completely unwilling to acknowledge the fact that it was selling Palbociclib, the court was constrained to hold the defendan

Patent infringement: HC orders Triveni Chemicals to pay Rs 2 cr to Pfizer

Pfizer Inc. and its group companies had filed a suit in the court against Triveni Interchem Private Limited & others accusing the for infringing their patent(IN 218291) for the compound Palbociclib